Precision for Medicine
In Brief This Week: Illumina, Sophia Genetics, Thermo Fisher, Precision for Medicine, More
News items for the week of May 27, 2024.
In purchasing startup SolveBio, Precision for Medicine's QuartzBio saw an opportunity to augment its genomic and clinical data analytics during a growth phase.
Precision for Medicine's QuartzBio Acquires Genomic Data Analytics Firm SolveBio
QuartzBio expects SolveBio's genomics and clinical data analytics technology to accelerate biomarker discovery in pursuit of precision therapies.
Although Illumina's failure to acquire Pacific Biosciences stood out in 2019, the upward trend in M&A activity in the omics space in 2018 continued last year.
Akoya Biosciences, Precision for Medicine to Develop Liquid Biopsy, Tissue Biomarker Tests
The team will combine Akoya's Vectra Polaris system with Precision for Medicine's Apostream tool to validate companion diagnostics and assess drug efficacy.
Jan 2, 2019
Oct 16, 2018
Precision for Medicine Acquires ApoCell
Mar 22, 2016
Precision for Medicine to Acquire ACT Oncology
Apr 16, 2009